Grifols SA
MAD:GRF

Watchlist Manager
Grifols SA Logo
Grifols SA
MAD:GRF
Watchlist
Price: 9.24 EUR 0.41% Market Closed
Market Cap: 6.3B EUR
Have any thoughts about
Grifols SA?
Write Note

Grifols SA
Investor Relations

Grifols SA, a global healthcare giant based in Barcelona, Spain, has carved its niche in the world through its pioneering work with plasma-derived medicines. Founded in 1940, the company has grown from a small family business into one of the world leaders in the production and development of biopharmaceuticals, particularly those derived from human plasma. Grifols operates a robust network of plasma donation centers, primarily in the United States, where it sources its primary raw material. The company's meticulous process involves collecting plasma from donors, which is then transported to sophisticated manufacturing facilities. Here, this vital fluid is fractionated into various components used to create life-saving treatments. These treatments address a spectrum of conditions, including hemophilia, immune deficiencies, and neurological issues, highlighting Grifols' integral role in advancing healthcare solutions.

Grifols' business model is astutely designed to capitalize on the high demand for plasma-derived therapies, ensuring a steady stream of revenue. By vertically integrating its operations—from plasma collection through to product distribution—Grifols maintains stringent quality control and operational efficiency, driving down costs and enhancing margins. The company's segmentation includes Bioscience, which focuses on plasma-derived therapies; Diagnostic, which involves manufacturing tools and reagents for clinical analysis; and Hospital, which manages pharmacy and healthcare logistics products. Furthermore, the company has ventured into bio supplies, supplying biological materials for non-therapeutic use to life-science research. With a deep commitment to innovation and strategic acquisitions, Grifols stays ahead in the competitive biopharmaceutical landscape while fostering a direct link between donor generosity and patient needs, ensuring that its growth story has a profound impact on global health.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Jose Ignacio Abia Buenache
CEO & Director
No Bio Available
Mr. Alfredo Arroyo Guerra CPA
CFO & VP
No Bio Available
Mr. Lluis Pons Gomez
Senior Vice President of Strategy & COO Office
No Bio Available
Ms. Nuria Pascual Lapeña
VP of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer
No Bio Available
Mr. David Ian Bell
Chief Corporate Development, Legal & Data Protection Officer
No Bio Available
Ms. Maria Teresa-Rioné Llano
Chief Communications Officer
No Bio Available
Mr. Camille Alpi
Chief Human Resources & Talent Officer
No Bio Available
Mr. Vicente Blanquer Torre
Chief Quality Officer
No Bio Available
Mr. Sergio Roura Adell
President of Commercial Tech Support
No Bio Available
Mr. Víctor Grifols Deu
Executive Director
No Bio Available

Contacts

Address
BARCELONA
Barcelona
C/ Jesus y Maria, 6
Contacts
+34935710000.0
www.grifols.com